Please login to the form below

Not currently logged in
Email:
Password:

Digital intelligence blog

Pharma insight on digital marketing, social media, mobile apps, online video, websites and interactive healthcare tools

Pfizer invests in Swedish digital health firm

AMRA's technology transforms MRI images into precise fat and muscle measurements 

digital pharma healthPfizer's venture capital arm has invested in AMRA, a Swedish digital health firm that was the first in the world to transform images from a six-minute whole body MRI scan into precise fat and muscle measurements.

Pfizer Venture Investments, in conjunction with Novo Seeds and Industrifonden, has put $9m into AMRA, whose areas of focus include obesity, diabetes, oncology and rare diseases.

Bill Burkoth, executive director at Pfizer Venture Investments said: “Pfizer Venture Investments invests in emerging companies developing technologies that can enhance Pfizer's pipeline and shape the future of our industry.

“AMRA's disruptive technology offers a personalised medicine approach to identify those at-risk of poor metabolic health outcomes. We are pleased to assist AMRA in making significant progress in this field.”

Headquartered in Sweden, AMRA was founded in 2010 as a digital health spin-out of the Center for Medical Image Science and Visualization (CMIV), the Department of Biomedical Engineering (IMT), and the Department of Medicine and Health (IMH) at Linköping University.

Following the new investment AMRA's plans include setting up a US subsidiary and expand its network among leading researchers and pharmaceutical companies.

In doing so its aim is to support patient stratification in clinical trials, the understanding of treatment effects on body composition, and the detection of early signs of treatment efficacy.

“AMRA is now one step closer to redefining obesity,” the firm said in a statement.

23rd January 2017

From: Healthcare

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Lucid Group Communications Limited

WE’RE ON A MISSION To enhance patients’ lives through communication that changes behaviour and improves patient health outcomes....

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics